Radiation treatment for medulloblastoma. A 21-year review

M. P. Berry, R. D T Jenkin, C. W. Keen, B. D. Nair, W. J. Simpson

    Research output: Contribution to journalArticlepeer-review

    186 Citations (Scopus)


    One hundred and twenty-two patients with medulloblastoma received postoperative irradiation at the Princess Margaret Hospital, Toronto, from 1958 to 1978, inclusive. The surgical procedure in these patients was total resection (44 patients), subtotal resection (66 patients), or biopsy alone (12 patients). Twenty-five patients received adjuvant chemotherapy. Overall 5- and 10-year survival rates were 56% and 43%, respectively. Improved survival rates were associated with an increased degree of resection and with posterior fossa radiation doses of 5200 rads or more. The posterior fossa was the common site of first relapse (in 56 patients, 46%). Systemic metastases at first relapse occurred in 18 of 52 patients (35%), and were associated with the use of ventriculosystemic shunts. Millipore filters did not prevent systemic relapse in shunted patients. A subset of 15 patients who received a posterior fossa dose of 5200 rads or more after a total resection had a 5-year survival rate of 77%, which remained constant to 10 years. This result is considered to be the upper limit that can be achieved by current treatment methods.

    Original languageEnglish
    Pages (from-to)43-51
    Number of pages9
    JournalJournal of Neurosurgery
    Issue number1
    Publication statusPublished - 1981


    Dive into the research topics of 'Radiation treatment for medulloblastoma. A 21-year review'. Together they form a unique fingerprint.

    Cite this